Tuesday, April 11, 2017

Asia-Pacific Clot Management Devices Market Outlook to 2021: Ken Research

Asia-Pacific Clot Management Devices Market Outlook to 2021, provides key market data on the Asia-Pacific Clot Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments-Peripheral Venous Thrombectomy Devices and Embolectomy Balloon Catheters.
Asia Pacific Clot Management Devices Market
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.
The data in the report is derived from dynamic market forecast models. Global Data uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Key topics covered in report
Asia Pacific Clot Management Devices Market
Asia Pacific Clot Management Devices Market Size
Asia Pacific Clot Management Devices Market Share
Asia Pacific Clot Management Devices Market Growth
Asia Pacific Clot Management Devices Market Outlook
Asia Pacific Clot Management Devices Market Analysis
Asia Pacific Clot Management Devices Market Revenue
Asia Pacific Clot Management Devices Market Research
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , ,

North America Operating Room Equipment Market Outlook to 2021: Ken Research

“North America Operating Room Equipment Market Outlook to 2021” provides key market data on the North America Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments-Operating Room Tables, Operating Room Lights and Surgical Booms.
North America Operating Room Equipment Market
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Market size for Operating Room Equipment market segments-Operating Room Tables, Operating Room Lights and Surgical Booms.
Annualized market revenues (USD million), volume (units) and average selling price ( USD ) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
2014 company shares and distribution share data for Operating Room Equipment market.
Global corporate-level profiles of key companies operating within the North America Operating Room Equipment market.
Key players covered include Steris Corporation, Stryker Corporation, Skytron, LLC, Getinge AB and others.
Key topics covered in report
North America Operating Room Equipment Market
North America Operating Room Equipment Volume
North America Operating Room Equipment Market Size
North America Operating Room Equipment Market Share
North America Operating Room Equipment Market Outlook
North America Operating Room Equipment Market Revenue
North America Operating Room Equipment Market Analysis
North America Operating Room Equipment Market Research
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , ,

UAE Electronic Security Market is Expected to Reach USD 370 Million in Future – ken Research

The market for electronic security  was still in its infancy stage in many Middle East countries which attracted many global players to establish their offices in the region. Axis communication opened its first office in 2013 in the region.
Government continued to remain the major contributor in the real estate sector, participation by government was both through direct lending through outside market mechanism and participation of government through state controlled banking system. This helped the market to recover faster than expected; creating demand for electronic security devices in the real estate sector for both commercial and residential buildings.




Rise in demand for facilities management had also been one of the key drivers for growth of electronic security system in the region. These devices help in better monitoring the working environment to improve efficiency.
A large sum of money in electronic security is spent in tourism and related industries. Such investments include both government (securing key markets, tourist destinations and transport facilities) and private sector (hotels, spas, restaurants and recreational parks.
Rise in demand for smart home solution had a positive impact on the market as it led to demand for electronically controlled surveillance system that monitors each and every movement of the individual in an area and control the features accordingly.
In 2016, market for video surveillance retained its high market share on account of growth in demand from places experiencing significant footfall such as malls, markets, and other places of tourist destinations.
The video surveillance systems comprise of products such as CCTV cameras, which can be further classified as analog and IP-based. The fire detection systems segment is government regulated and these systems have experienced a gradual upsurge in demand as it is mandatory to deploy fire alarm systems in all commercial and residential buildings. Intrusion alert system/Intrusion alarms are most popular amongst banks and financial institutions. These products generated significant demand from residential sector.
Honeywell offers electronic security for commercial building in a wide range of products for small offices, commercial solutions and enterprise solutions. Its range of products include Video systems, intrusion alarm systems, voice alarm systems, fire alarm system and access control system along with software support of these products.
Bosch products are best suited to be used at airports, railway stations, stadiums, conventions centers, and industrial sectors.
For more information on the market research report please refer to the below link:
https://www.kenresearch.com/defense-and-security/security-devices/uae-electronic-security-market/94351-16.html
Related Reports by Ken Research
India Electronic Security Industry Potential to 2020 - Growing System Integrators Market with Real Estate Development in Upcoming Smart Cities
China Electronic Security Market Outlook to 2019 - Public Infrastructure Spending and Innovations to Drive the Future
Malaysia Electronic Security Equipment Industry Outlook to 2018 - Increasing Demand for CCTV Cameras to Spur Growth

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249



Posted by at No comments:
Labels: , , , ,
Location: United Arab Emirates

Reduction in Prices of LED, Low Market Penetration and Increasing Awareness campaigns about Energy Savings Supported the Sales of LED in US: Ken Research

As per the report titled “US LED Lighting Market Outlook to 2021” by Ken Research, the overall LED lighting market of the US is expected to generate revenue of USD 23.6 billion by 2021 by growing at an expected 5 year CAGR of 25.7%.
Global Led Lighting Market
The US, being considered as the most developed country of the world has witnessed a positive change in terms of energy saving programs. The Federal Energy Management Program (FEMP) of the US government helps organizations and agencies in achieving their energy related goals and requirements along with the reduction of greenhouse effects. Many NGOs have tied up with the government to make people aware about the energy conservation techniques, out of which using LEDs is one such way. LED lights are considered to be 80% more efficient than regular lighting methods used by people. Since they are expensive, they are often offered at subsidized prices with other benefits so that the people can afford and switch to low energy consumption techniques. For instance, corporate tax incentives are provided to the companies in Kentucky if they use LED lights in their offices. People of the US are connected with various organizations to make them aware about the ways in which they can reduce their energy consumption. This has been a significant trend wherein both LED manufacturing companies and the government are trying to make people know about the positive impacts of using these lights over traditional means. In order to make people aware, the government has also adopted to use LED lights for street lighting purposes. This builds trust among people that the lights are safe and energy efficient as the government is also using the similar technology
The US and many countries in the European Union have instituted plans to institute, government regulations and programs designed to encourage or mandate increased energy efficiency in lighting. These actions include in certain cases banning the sale after specified dates of certain forms of incandescent lighting, which is advancing the adoption of more energy efficient lighting solutions such as LEDs. In addition, the growing demand for electricity is increasingly driving utilities and governmental agencies to provide financial incentives such as rebates for energy efficient lighting technologies in an effort to mitigate the need for investments in new electricity generation capacity.
Despite the efforts of government and LED manufacturing companies to shift people from traditional lighting to energy saving LED lights, there still has been a low penetration of LED lighting techniques in the US according to Research Analyst at Ken Research. The overall electricity market is driven by the ongoing ways of fluorescent lights wherein the market players in the LED manufacturing sector are trying to penetrate the market by making people aware about the benefits associated with using such lights. Low penetration of each type of LED light in the market is considered to be the most crucial challenge in the industry.
Key Topics Covered in the Report:
Led Lighting in the US
United States Led Industry
Global Led Lighting Market
Technology Led Lighting US
Led Lamps Market Trends US
US Led Lighting Market Worth
US Led Lighting Manufacturers
Lighting & Bulb Manufacturing in the US
Industrial & Commercial Led Lighting Market
Led Lamps Revenue US
Cree Led Lights Sales in United States
Philips Revenue Led Lights
For more coverage click on the link below:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Monday, April 10, 2017

HER2-Negative/HR+ and Triple Negative Breast Cancer-Global Drug Forecast and Market Analysis to 2025: ken Research

Human epidermal growth factor receptor type 2 (HER2-) breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. HER2-negative breast cancer can be subdivided into hormone receptor-positive (HER2-/HR+), and triple negative breast cancer (TNBC). The prognoses of HER2-/HR+ and TNBC differ dramatically, as patients with TNBC progress more rapidly towards metastatic disease and only respond to chemotherapy agents. A large number of pipeline agents are being developed in HER2-/HR+ and/or TNBC, and are likely to change the treatment paradigm for these patients.
Global Breast Cancer Drug Market Research
This report highlights the significant unmet need for expansion in the HER2- breast cancer marker across the eight major markets; it also discusses the associated commercial opportunities for new market entrants to gain a foothold in the market. GlobalData anticipates the HER2- breast cancer market to almost double, from $5.43B to $10.58B, over the forecast period of 2015-2025. The key drivers will be the incorporation of CDK4/6 inhibitors into the first-line metastatic setting and the rise of new targeted therapies and immunotherapies.
Key Findings
In 2015, the value of the HER2- breast cancer market in the 8MM was estimated to be $5.43B. This is forecast to grow to $10.58B by the end of the forecast period, with China the main driver of growth.
The largest driver will be the incorporation of premium priced CDK4/6 inhibitors into the first line setting. Pfizer's Ibrance and Novartis' ribociclib are expected to each reach blockbuster status by the end of the forecast period.
However, patent expiries of several blockbuster drugs and pricing difficulties are expected to limit growth in the HER2- breast cancer market over the forecast period.
Large market opportunities remain for the development of novel therapies in patients who acquire resistance to endocrine therapy.
Key topics covered in report
Prognosis for Breast Cancer
Triple Negative Breast Cancer
Global Breast Cancer Drug Forecast
Molecular Subtypes of Breast Cancer
Global Breast Cancer Drug Market Size
Global Breast Cancer Drug Market Share
Global Breast Cancer Drug Market Analysis
Global Breast Cancer Drug Market Research
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Dyslipidemia-Global Drug Forecast and Market Analysis to 2025: Ken Research

Global Data estimates sales of dyslipidemia therapeutics to be approximately $11.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The dyslipidemia market will grow at a strong CAGR of 10.1% over the forecast period, reaching sales of $29.2B by 2025. The US is the largest market for dyslipidemia therapies, contributing approximately 61.5% of total sales in the base year. Global Data expects uptake of the revolutionary class of PCSK9 targeting biologics to be the strongest driver of growth in the dyslipidemia market in the 7MM, reaching peak sales of $9.5B in 2025. Despite the launch of such efficacious lipid-lowering therapies, there is ample opportunity for pipeline drugs targeting the broader mixed dyslipidemia market. As pricing is expected to be the strongest barrier to uptake in the dyslipidemia, space, cost-effective therapies will be more successful at penetrating the market.
Dyslipidemia Global Drug Forecast
The major drivers for growth across the 7MM in the dyslipidemia market during the forecast period will be the launch of the novel PCSK9 targeting therapies.
KOLs interviewed by GlobalData opined that ETC-1002 (bempedoic acid) will be a strong contender, and will displace ezetimibe as the standard of care for statin intolerant patients.
The highest revenue generators in the 7MM market at the end of 2025 will be the PCSK9 targeting therapies and ETC-1002.
In other interviews, KOLs highlighted that the greatest unmet need in the dyslipidemia space is disease awareness, with a large proportion of patients going underdiagnosed, and of those who are diagnosed, drug treatment rates are also low.
Key topics covered in report
Dyslipidemia Global Drug Forecast
Dyslipidemia Global Drug Market Size
Dyslipidemia Global Drug Market Share
Dyslipidemia Global Drug Market Growth
Dyslipidemia Global Drug Market Analysis
Dyslipidemia Global Drug Market Research
Dyslipidemia Fredrickson Classification System
Risk Factors and Comorbidities for Dyslipidemia
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , ,

Hepatitis C Virus (Hcv) Therapeutics-Global Drug Forecast and Market Analysis To 2025: Ken Research

The hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections of the liver and, if left untreated, can result in fibrosis, permanent liver damage (cirrhosis), HCC, and eventually death. A member of the Flaviviridae viral family and hepacivirus genus, HCV can be classified into six major genotypes, with many additional subtypes within each genotype. While genotype 1 (GT1) causes almost half of HCV infections, all six major genotypes (GT1-6) are prevalent worldwide. The genetic diversity of HCV strains, even within the same host, originates from the low fidelity of the ribonucleic acid (RNA) polymerase, and is thought to account for viral resistance when HCV is treated with a single drug.
Hepatitis C Virus Therapeutics Market Research
During the last few years, the hepatitis C treatment landscape has experienced successive waves of revolutionary change, and is now dominated by high-performance regimens comprising a new generation direct acting antivirals (DAAs). The treatment arsenal has rapidly expanded from only one unsatisfactory option-peginterferon plus ribavirin-to a collection of combination and fixed-dose combination regimens that can cure most patients in as little as 8?12 weeks, many without the use of interferon and/or ribavirin. Currently, these interferon-free and interferon-sparing DAA regimens dominate the treatment landscape as they combine a very high cure rate with improved tolerability and simplified dosing.
Global Data estimates that drug sales for hepatitis C in 2015 were approximately $21.7 billion across the 9MM. The global hepatitis C market is expected to experience a steady decline during the forecast period resulting in total sales of $17.5 billion by 2025, translating into a negative Compound Annual Growth Rate (CAGR) of 2.1%. The decline in sales will be most prominent in the US and in France, Germany, and the UK, while the southern European countries, Spain and Italy, as well as China, will see constant or even increasing market sizes during the forecast period.
The launch of multiple pan-genotypic DAA regimens will provide improved efficacy profiles for difficult-to-treat patients, including patients infected with genotype 3 (GT3), individuals with renal failure, and patients with decompensated liver cirrhosis.
The main barrier of future growth of the global HCV market will originate from the declining prevalence rates in most countries. Driven by modest treatment rates and excellent cure rates, the patient pools in most countries will steadily decline throughout the forecast; several markets will see significantly reduced total patient pools by 2025.
Key topics covered in report
HCV Genotypes Prevalent
Modes of HCV Transmission
Hepatitis C Virus Genotype Description
Hepatitis C Virus Therapeutics Drug Forecast
Symptoms of Acute and Chronic HCV Infection
Hepatitis C Virus Therapeutics Market Research
Global Hepatitis C Virus Therapeutics Market Analysis
Risk Factors and Comorbidities Associated with HCV Infection
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)